Searched for
PFIZER ELI LILLY TARIFF DEALS
Exporters see higher US enquiries but low order conversionsIndian exporters, particularly in the chemicals, textiles, and handicrafts sectors, are experiencing a notable increase in inquiries from U...- DBS completes $1 billion synthetic securitisation in first for a Singapore bankSingapore's largest bank, DBS Group, has successfully completed a groundbreaking synthetic securitisation deal involving a $1 billion corpo...
- Dow Jones hits record above 52,000 as Alphabet debuts in index, S&P 500 climbs and Nasdaq jumps over 2% as tech stocks lead Wall Street rally - here's how US stock market performed today (June 29)S&P 500, Dow Jones and Nasdaq today June 29: The US stock market started the shortened trading week with solid gains as the Dow Jones close...
- Indian ambassador Kwatra meets senior US defence official Elbridge ColbyIndia's Ambassador to the US, Vinay Mohan Kwatra, met with senior US defence official Elbridge Colby at the Pentagon. Their discussion cent...
- Trump threatens 100% tariff on nations taxing US tech giants, warns trade deals won't matterUS President Donald Trump has issued a stern warning, threatening a hefty 100% tariff on all goods from nations implementing digital servic...
- AI is plowing through the workplace. This new group wants to help people adapt and have jobsA newly formed bipartisan nonprofit named RAISE US is set to launch with over $500 million aimed at tackling job losses anticipated from ar...
- US trade deal to be on the day India secures tariff edge: Piyush GoyalIndia's impending trade agreement with the US is centered on gaining a tariff advantage over competitors like China and Vietnam, as asserte...
- Centre set to tighten oversight of pharma packaging materialsIndia is set to implement a mandatory registration for printed pharmaceutical packaging manufacturers to combat counterfeit drugs. This mov...
- Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...
- India-US trade deal enters crucial phase as Section 301 and tariff deadline loom largeIndia and the US are in the final stages of trade deal negotiations, with a July 24 deadline looming. A key sticking point is Section 301 o...
- India, US move closer to interim trade deal after Goyal-Greer talksIndia and the United States have made significant headway in their Bilateral Trade Agreement negotiations, with both nations expressing str...
- India seeks tariff advantage over peers in push to finalise US trade dealIndia's trade minister, Piyush Goyal, revealed on Monday that a trade agreement with the United States is experiencing delays. The primary ...
- Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- Global drugmakers rush to boost US presence as tariff threat loomsGlobal drug companies are boosting U.S. production and stockpiling medicines. This is a response to potential tariffs on branded drugs. Com...
- India's Electronics Mart eyes new markets as tech hubs fear job lossesElectronics Mart India is diversifying its store presence beyond Hyderabad due to concerns about potential AI-driven job losses impacting c...
- Eli Lilly's Alzheimer's drug donanemab approved in India, but neurologists flag cost, access barriersA new drug for Alzheimer's, donanemab, has arrived in India. It aims to slow the disease's progression by clearing brain plaques. While off...
- UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
- US stocks: Lilly shares rise on hopes that next-gen drug will extend lead in weight-loss marketLilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients with obesity...
- Eli Lilly says next-gen obesity drug curbs sleep apnea, among other benefitsEli Lilly presented trial results for its new obesity drug retatrutide. The drug significantly reduced sleep apnea severity and knee osteoa...
Load More
